however, other factors, such as side effects and route of administration (most all GLP1 receptor agonists are administered via subcutaneous injection) can also contribute to patients discontinuing their GLP1 receptor agonists
p = 0.001)
doi: 10.3389/fnut.2022.907789 107
[DOI] [PubMed] [Google Scholar] 78.Astrup A., Rssner S., Van Gaal L., Rissanen A., Niskanen L., Al Hakim M., Madsen J., Rasmussen M.F., Lean M.E
Different weight loss medications demonstrate varying gastrointestinal side effect profiles, which can inform treatment selection for patients particularly concerned about diarrhea
Our platform connects you with licensed providers who evaluate your medical history and goals to create a plan that is right for you